Lipoxins: revelations on resolution
- 1 August 2001
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 22 (8) , 391-395
- https://doi.org/10.1016/s0165-6147(00)01771-5
Abstract
No abstract availableKeywords
Funding Information
- European Commission
- Enterprise Ireland
- Wellcome Trust
- Health Research Board
This publication has 21 references indexed in Scilit:
- The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2Journal of Biological Chemistry, 2001
- Selectivity of Recombinant Human Leukotriene D4, Leukotriene B4, and Lipoxin A4 Receptors with Aspirin-Triggered 15-epi-LXA4 and Regulation of Vascular and Inflammatory ResponsesThe American Journal of Pathology, 2001
- Lipoxin A4 Antagonizes the Mitogenic Effects of Leukotriene D4 in Human Renal Mesangial CellsJournal of Biological Chemistry, 2000
- Lipoxin A4 Inhibits IL-1β-Induced IL-6, IL-8, and Matrix Metalloproteinase-3 Production in Human Synovial Fibroblasts and Enhances Synthesis of Tissue Inhibitors of MetalloproteinasesThe Journal of Immunology, 2000
- Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusionJournal of Clinical Investigation, 1999
- Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine AxisThe Journal of Experimental Medicine, 1999
- Lipoxin A4: A New Class of Ligand for the Ah ReceptorBiochemistry, 1999
- Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs.Journal of Clinical Investigation, 1998
- Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 ReleaseThe Journal of Experimental Medicine, 1998
- Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): A jungle of cell-cell interactions or a therapeutic opportunity?Prostaglandins, 1997